RecruitingNot Applicable

Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells

France25 participantsStarted 2024-11-19

Plain-language summary

Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant woman * Singleton pregnancy * Pregnancy between 7 and 16 weeks of amenorrhea (WA) * Woman ≥ 18 years * Woman who has signed an informed consent * Woman affiliated to social security or equivalent scheme Exclusions Criteria: * Person under guardianship or curatorship * Person placed under legal protection * Person unable to provide the participant with informed consent.

What they're measuring

Establish an ultra-early detection method

Timeframe: Visit 2 (Week 20-24)

Trial details

NCT IDNCT06523543

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-08-30

Contact for this trial

Vincent GATINOIS, MD

0 67 33 68 66 v-gatinois@chu-montpellier.fr

View on ClinicalTrials.gov More Pregnant Women trials